We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. We may also share information about your use of our site with our social media, advertising and analytics partners. Read more about our Privacy Policy.

I got it!

Pain Therapeutics 2017

Pain Therapeutics 2017 returns to London this spring, providing a focal point to discuss new clinical advancements, therapeutic developments and strategies towards minimising opioid dependency.

Created with an expert scientific advisory board, SMi’s 17th annual Pain Therapeutics conference will hone in on the latest innovations and novel approaches to pain therapy and analgesic drugs as well as look at the practicalities of using animal models and translational biomarkers in pain research.

Aimed at an audience of scientific leaders and senior specialists in neuroscience, CNS, clinical operations and pharmacology, Pain Therapeutics 2017 will keep attendees at the forefront of medical breakthroughs to adapt to the growing need towards minimising opioid dependency and new drug discovery.

Presentations from a selection of hand-picked pharmaceutical companies currently developing novel treatments in pain, will provide delegates with an understanding on key topics such as product formulation; opioid addiction; translational pain research; and breakthroughs in drug discovery.

Interactive workshops and exclusive new findings from phase II clinical trials will be just some of the highlights at the 17th annual show when it returns to London this spring.

KEYNOTE SPEAKERS INCLUDE:

  • Prof Anthony Jones, Professor of Neuro-Rheumatology, University of Manchester
  • Dr Steven Kamerling, Therapeutic Area Head for Pain, Inflammation and Oncology, Zoetis
  • Dr Joseph W. Stauffer, Chief Medical Officer, Cara Therapeutics Inc
  • Dr Stephen Doberstein, Senior Vice President and Chief Scientific Officer, Nektar Pharmaceuticals
  • Dr Iain Chessell, Head of Neuroscience, AstraZeneca
  • Dr Randall Stevens, Chief Medical Officer, Centrexion Therapeutics Corp
  • Dr Richard Butt, Chief Executive Officer, Apollo Therapeutics
  • Prof Theo Meert, Head of Global Government Grant Office, Janssen Pharmaceutica NV
  • Dr Narender Gavva, Scientific Director, Amgen
  • Dr Thomas Christoph, Head of Pharmacology and Biomarker Development, Grunenthal GmbH
  • Dr Ian Bell, Principal Scientist, MSD, USA

The packed agenda also features talks from Lilly UK, Novartis, Pharmaleads, Mundipharma Research and more!

REASONS TO ATTEND IN 2017

  • Awareness of new guideline on the clinical development of medicinal products intended for the treatment of pain
  • Strategies and real case studies to minimise risk of opioid dependence
  • Evaluate the translation gap with case studies from a pre-clinical and clinical perspective
  • Explore the latest in the area of Neuropathic pain for 2017 with the latest case studies from top pharma companies
  • Examine the use of animal models to study pain pathways

Visit the website for further details at http://www.pain-therapeutics.co.uk/euagenda or contact the team on +44 (0)20 7827 6000 / email: events@smi-online.co.uk

When

22 May 2017 @ 12:00 am

23 May 2017 @ 12:01 am

Duration: 1 days

Where

Copthorne Tara Hotel

1 Scarsdale Place

Kensington

United Kingdom

Organised by

SMi Group Ltd.

+44 (0) 20 7827 6000

Premium Events in Science

Recent Publications in Science

Recent Videos in Science

Recent News in Science

As one of the world’s leading R&D conference combined with an international exhibition, the EUBCE represents the leading platform for the collection, exchange and dissemination of scientific know-how in the field of biomass. Be part of the 26th European Biomass Conference and Exhibition and present your results to specialists and decision makers operating at the top end of the biomass and bioenergy sector. Submit your abstract by 6th November 2017.

@http://ec.europa.eu/research/index.cfm?pg=events&eventcode=A92B8FA1-EE7A-2A57-EA02F4BD1A995925 - 21 Nov 2017 09:37

In the context of the 2nd HBP Student Conference, young researchers from the fields of neuroscience, brain medicine and computer science receive the possibility to exchange ideas and perspectives and discuss various aspects of their particular fields of expertise relevant to the Human Brain Project. The conference offers a variety of discussion sessions, lectures and social events. Through working across boundaries and linking the various fields, it serves as a platform for both intra- and interdisciplinary exchange and is a great opportunity for extensive scientific discussions among peers and faculty, and also a fertile soil for new, innovative ideas. Conference structure Keynote lectures Discussion sessions Student talks Poster presentations Discussion panel Social events We are looking for original high-quality submissions containing innovative research from all fields relating to the HBP research programme. Contributions emphasising theoretical and empirical foundations are just as welcome as new approaches to specific questions concerning the Subprojects of the HBP. Finally, we particularly encourage submissions introducing new and relevant problems, concepts and ideas with the potential to inspire the research community – even if the approach is at an early stage of development. All participants may submit an abstract and will have the opportunity to present their work. Presentations will include a brief oral presentation, a poster, or both. Abstracts to be submitted before 11 October 2017. Childcare will be offered during the conference. Participants have to indicate in the registration form if this service is required.

@http://ec.europa.eu/research/index.cfm?pg=events&eventcode=A900108E-D876-454A-D3AAB5F9B971D7F3 - 21 Nov 2017 09:34

Deforestation emits CO2 that is roughly equivalent to 10% of global fossil fuel emissions, says ERC grantee Guido v… https://t.co/BMwApwnLRq

@ERC_Research - 21 Nov 2017 09:33

Recent Speakers in Science

Jan Warner

3 events , Science

Hyoungseop Kim

1 events , Science